Patents by Inventor Marie-Emmanuelle Le Guern

Marie-Emmanuelle Le Guern has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • for the treatment of mood disorders
    Patent number: 11872257
    Abstract: The present invention relates to Saccharomyces boulardii yeast cells, for use in the prevention or treatment of mood disorders, in a person.
    Type: Grant
    Filed: August 10, 2018
    Date of Patent: January 16, 2024
    Assignee: BIOCODEX
    Inventors: Emmanuelle Simon O'Brien, Marc Verleye, Marie-Emmanuelle Le Guern
  • PHARMACEUTICAL COMPOSITION USEFUL FOR PROMOTING OSTEOBLASTOGENESIS
    Publication number: 20230277611
    Abstract: A pharmaceutical composition for promoting osteoblastogenesis, in particular a yeast cell derived product for use for promoting osteoblastogenesis in an individual. The yeast cell-derived product may be derived from yeast cells of the genus Saccharomyces and from yeast cells of the species Saccharomyces boulardii.
    Type: Application
    Filed: September 2, 2021
    Publication date: September 7, 2023
    Applicant: BIOCODEX
    Inventors: Marie-Emmanuelle LE GUERN, Marc VERLEYE
  • Pharmacological treatment of obsessive-compulsive disorder
    Patent number: 10696647
    Abstract: The present invention relates to a compound of the following formula (I): or a pharmaceutically acceptable salt thereof, for use in the prevention or treatment of obsessions and/or compulsions in an individual.
    Type: Grant
    Filed: November 20, 2014
    Date of Patent: June 30, 2020
    Assignee: BIOCODEX
    Inventors: Marc Verleye, Marie-Emmanuelle Le Guern
  • SACCHAROMYCES BOULARDII FOR THE TREATMENT OF MOOD DISORDERS
    Publication number: 20200179469
    Abstract: The present invention relates to Saccharomyces boulardii yeast cells, for use in the prevention or treatment of mood disorders, in a person.
    Type: Application
    Filed: August 10, 2018
    Publication date: June 11, 2020
    Inventors: Emmanuelle SIMON O'BRIEN, Marc VERLEYE, Marie-Emmanuelle LE GUERN
  • TREATMENT OF DISEASES ASSOCIATED WITH A DYSREGULATION OF THE mTOR PATHWAY
    Publication number: 20200179335
    Abstract: The present invention relates to a compound of the following formula (I): or a pharmaceutically acceptable salt, hydrate or solvate thereof, for use in the prevention or treatment of a disease associated with a dysregulation of the mTOR pathway in an individual.
    Type: Application
    Filed: May 30, 2018
    Publication date: June 11, 2020
    Inventors: Véronique RIBAN, Marc VERLEYE, Marie-Emmanuelle LE GUERN
  • Compounds and methods for treating autism spectrum disorders
    Patent number: 10675266
    Abstract: The present invention relates to a compound of the following formula (I): or a pharmaceutically acceptable salt thereof, for use in the prevention or treatment of autism spectrum disorders (ASD).
    Type: Grant
    Filed: July 23, 2018
    Date of Patent: June 9, 2020
    Assignee: BIOCODEX
    Inventors: Bernard Hublot, Rene Levy, Marie-Emmanuelle Le Guern
  • Compositions and methods for preventing infections
    Patent number: 10525092
    Abstract: The present invention relates to a dietary supplement or pharmaceutical composition, comprising lyophylized Saccharomyces boulardii as an active ingredient and as sole probiotic, optionally in association with a pharmaceutically acceptable vehicle, wherein the composition is in a closed vial a having a first airtight compartment comprising lyophilized S. boulardii powder, and a second compartment comprising a solution, wherein the first and second compartment can be brought in airtight communication with one another to yield a suspension of S. boulardii to be administered to an individual upon opening of the vial.
    Type: Grant
    Filed: June 11, 2015
    Date of Patent: January 7, 2020
    Assignee: BIOCODEX
    Inventors: Jean-Marie Lefevre, Gilles Renaud, Marie-Emmanuelle Le Guern
  • COMPOSITION USEFUL FOR THE PREPARATION OF A SUPPOSITORY
    Publication number: 20190142745
    Abstract: The present invention relates to a composition comprising a mixture of Saccharomyces boulardii cells and of a wax.
    Type: Application
    Filed: April 27, 2017
    Publication date: May 16, 2019
    Inventors: Anne BENOIST, Emilie FARGIER, Marie-Emmanuelle LE GUERN, Marc VERLEYE, Patrice TEWA, Xavier ZEISSER
  • COMPOUNDS AND METHODS FOR TREATING AUTISM SPECTRUM DISORDERS
    Publication number: 20180325864
    Abstract: The present invention relates to a compound of the following formula (I): or a pharmaceutically acceptable salt thereof, for use in the prevention or treatment of autism spectrum disorders (ASD).
    Type: Application
    Filed: July 23, 2018
    Publication date: November 15, 2018
    Inventors: Bernard HUBLOT, Rene LEVY, Marie-Emmanuelle LE GUERN
  • COMPOSITIONS AND METHODS FOR PREVENTING INFECTIONS
    Publication number: 20180153947
    Abstract: The present invention relates to a dietary supplement or pharmaceutical composition, comprising lyophylized Saccharomyces boulardii as an active ingredient and as sole probiotic, optionally in association with a pharmaceutically acceptable vehicle, wherein the composition is in a closed vial a having a first airtight compartment comprising lyophilized S. boulardii powder, and a second compartment comprising a solution, wherein the first and second compartment can be brought in airtight communication with one another to yield a suspension of S. boulardii to be administered to an individual upon opening of the vial.
    Type: Application
    Filed: June 11, 2015
    Publication date: June 7, 2018
    Inventors: Jean-Marie LEFEVRE, Gilles RENAUD, Marie-Emmanuelle LE GUERN
  • Treatment of degenerations and light-induced damage to the retina
    Patent number: 9872858
    Abstract: The present invention relates to a compound of the following formula (I): or a pharmaceutically acceptable salt thereof, to be used in the prevention or treatment of light-induced damage and/or a degeneration of the retina in a patient.
    Type: Grant
    Filed: January 28, 2015
    Date of Patent: January 23, 2018
    Assignee: BIOCODEX
    Inventors: Marc Verleye, Philippe Girard, Marie-Emmanuelle Le Guern
  • TREATMENT OF DEGENERATIONS AND LIGHT-INDUCED DAMAGE TO THE RETINA
    Publication number: 20170000798
    Abstract: The present invention relates to a compound of the following formula (I): or a pharmaceutically acceptable salt thereof, to be used in the prevention or treatment of light-induced damage and/or a degeneration of the retina in a patient.
    Type: Application
    Filed: January 28, 2015
    Publication date: January 5, 2017
    Inventors: Marc VERLEYE, Philippe GIRARD, Marie-Emmanuelle LE GUERN
  • PHARMACOLOGICAL TREATMENT OF ATTENTION DEFICIT AND/OR HYPERACTIVITY
    Publication number: 20160331723
    Abstract: The present invention relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof, for use in the prevention or treatment of attention deficit and/or hyperactivity in an individual.
    Type: Application
    Filed: December 17, 2014
    Publication date: November 17, 2016
    Inventors: Marc VERLEYE, Véronique RIBAN, Marie-Emmanuelle LE GUERN
  • PHARMACOLOGICAL TREATMENT OF OBSESSIVE-COMPULSIVE DISORDER
    Publication number: 20160289205
    Abstract: The present invention relates to a compound of the following formula (I): or a pharmaceutically acceptable salt thereof, for use in the prevention or treatment of obsessions and/or compulsions in an individual.
    Type: Application
    Filed: November 20, 2014
    Publication date: October 6, 2016
    Inventors: Marc VERLEYE, Marie-Emmanuelle LE GUERN
  • PHARMACEUTICAL COMPOSITION FOR REDUCING BODY FAT
    Publication number: 20160287649
    Abstract: The present invention relates to a pharmaceutical composition comprising, as active substance, Saccharomyces boulardii yeast cells, for use for reducing body fat in an individual.
    Type: Application
    Filed: November 7, 2014
    Publication date: October 6, 2016
    Inventors: Patrice D. CANI, Amandine EVERARD, Lucie GEURTS, Emilie FARGIER, Marc VERLEYE, Marie-Emmanuelle LE GUERN
  • Medicinal product for treating gastrointestinal ulcers
    Patent number: 9241961
    Abstract: The present invention relates to yeast cells for use in the prevention or treatment of gastric or intestinal ulcers.
    Type: Grant
    Filed: December 7, 2010
    Date of Patent: January 26, 2016
    Assignee: BIOCEDEX
    Inventors: Philippe Girard, Marie-Emmanuelle Le Guern, Marc Verleye, Bernard Hublot
  • Compound for use in the treatment of peripheral neuropathies
    Patent number: 8927600
    Abstract: The present invention relates to a compound of the following formula (I): or a pharmaceutically acceptable salt thereof, for use in the prevention or treatment of peripheral neuropathies.
    Type: Grant
    Filed: March 18, 2010
    Date of Patent: January 6, 2015
    Assignee: Biocodex
    Inventors: Marie-Emmanuelle Le Guern, Marc Verleye, Jean-Marie Gillardin, Bernard Hublot
  • Synergistic combination of analgesic compounds
    Patent number: 8598221
    Abstract: The present invention relates to a pharmaceutical composition comprising as active substances: at least one compound of the following general formula (I): and at least one inhibitor of type 2 cyclooxygenase (COX-2), notably for use in the prevention or treatment of pain.
    Type: Grant
    Filed: December 3, 2010
    Date of Patent: December 3, 2013
    Assignee: Biocodex
    Inventors: Philippe Girard, Marie-Emmanuelle Le Guern, Jean-Marie Gillardin, Bernard Hublot
  • Synergistic combination of analgesic compounds
    Patent number: 8575211
    Abstract: The present invention relates to a pharmaceutical composition comprising as active substances: at least one compound of the following general formula (I): and at least one compound of the following general formula (V): especially for its use in the prevention or treatment of pain.
    Type: Grant
    Filed: October 28, 2009
    Date of Patent: November 5, 2013
    Assignee: Biocodex
    Inventors: Philippe Girard, Marie-Emmanuelle Le Guern, Laurence Berthon-Cedille, Jean-Marie Gillardin, Bernard Hublot
  • Pharmaceutical composition intended for the prevention or for the treatment of cerebral oedemas
    Patent number: 8420644
    Abstract: The present invention relates to the use of at least one compound of formula (I) below: or at least one of the pharmaceutically acceptable salts thereof, for the preparation of a medicament intended for the prevention or for the treatment of cerebral edemas.
    Type: Grant
    Filed: June 5, 2006
    Date of Patent: April 16, 2013
    Assignee: Biocodex
    Inventors: Marie-Emmanuelle Le Guern, Philippe Girard, Jean-Marie Gillardin, Laurence Berthon-Cedille, Bernard Hublot